|
1
|
Aggarwal P: Cervical cancer: Can it be
prevented? World J Clin Oncol. 5:775–780. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang KL: Human papillomavirus and
vaccination in cervical cancer. Taiwan J Obstet Gynecol.
46:352–362. 2007. View Article : Google Scholar
|
|
3
|
Haedicke J and Iftner T: Human
papillomaviruses and cancer. Radiother Oncol. 108:397–402. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Almajhdi FN, Senger T, Amer HM, Gissmann L
and Öhlschläger P: Design of a highly effective therapeutic HPV16
E6/E7-specific DNA vaccine: Optimization by different ways of
sequence rearrangements (shuffling). PLoS One. 9:e1134612014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen S, Liao C, Lai Y, Fan Y, Lu G, Wang
H, Zhang X, Lin MC, Leng S and Kung HF: De-oncogenic HPV e6/e7
vaccine gets enhanced antigenicity and promotes tumoricidal synergy
with cisplatin. Acta Biochim Biophys Sin (Shanghai). 46:6–14. 2014.
View Article : Google Scholar
|
|
6
|
Duenas-Gonzalez A, Serrano-Olvera A,
Cetina L and Coronel J: New molecular targets against cervical
cancer. Int J Womens Health. 6:1023–1031. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boulet GA, Horvath CA, Berghmans S and
Bogers J: Human papillomavirus in cervical cancer screening:
important role as biomarker. Cancer Epidemiol Biomarkers Prevy.
17:810–817. 2008. View Article : Google Scholar
|
|
8
|
Fei ZW, Qiu MK, Qi BQ, Dai YX, Wang SQ,
Quan ZW, Liu YB and Ou JM: Oxymatrine suppresses proliferation and
induces apoptosis of hemangioma cells through inhibition of HIF-1α
signaling. Int J Immunopathol Pharmacol. 28:201–208. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo B, Zhang T, Su J, Wang K and Li X:
Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related
signaling pathways to suppress the proliferation and invasion of
gastric cancer cells. Cancer Chemother Pharmacol. 75:353–363. 2015.
View Article : Google Scholar
|
|
10
|
Li M, Su BS, Chang LH, Gao Q, Chen KL, An
P, Huang C, Yang J and Li ZF: Oxymatrine induces apoptosis in human
cervical cancer cells through guanine nucleotide depletion.
Anticancer Drugs. 25:161–173. 2014. View Article : Google Scholar
|
|
11
|
Wang B, Han Q and Zhu Y: Oxymatrine
inhibited cell proliferation by inducing apoptosis in human lung
cancer A549 cells. Biomed Mater Eng. 26(Suppl 1): S165–S172.
2015.PubMed/NCBI
|
|
12
|
Zhang Y, Sun S, Chen J, Ren P, Hu Y, Cao
Z, Sun H and Ding Y: Oxymatrine induces mitochondria dependent
apoptosis in human osteosarcoma MNNG/HOS cells through inhibition
of PI3K/Akt pathway. Tumour Biol. 35:1619–1625. 2014. View Article : Google Scholar
|
|
13
|
Guzman JR, Koo JS, Goldsmith JR, Mühlbauer
M, Narula A and Jobin C: Oxymatrine prevents NF-κB nuclear
translocation and ameliorates acute intestinal inflammation. Sci
Rep. 3:16292013. View Article : Google Scholar
|
|
14
|
Wang W, You RL, Qin WJ, Hai LN, Fang MJ,
Huang GH, Kang RX, Li MH, Qiao YF, Li JW, et al: Anti-tumor
activities of active ingredients in Compound Kushen Injection. Acta
Pharmacol Sin. 36:676–679. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ying XJ, Jin B, Chen XW, Xie J, XU HM and
Dong P: Oxymatrine downregulates HPV16E7 expression and inhibits
cell proliferation in laryngeal squamous cell carcinoma Hep-2 cells
in vitro. BioMed Res Int. 2015:1503902015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun M, Cao H, Sun L, Dong S, Bian Y, Han
J, Zhang L, Ren S, Hu Y, Liu C, et al: Antitumor activities of
kushen: Literature review. Evid Based Complement Alternat Med.
2012:3732192012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamazaki M: The pharmacological studies on
matrine and oxymatrine. Yakugaku Zasshi. 120:1025–1033. 2000.In
Japanese. PubMed/NCBI
|
|
18
|
Jiang G, Liu X, Wang M, Chen H, Chen Z and
Qiu T: Oxymatrine ameliorates renal ischemia-reperfusion injury
from oxidative stress through Nrf2/HO-1 pathway. Acta Cir Bras.
30:422–429. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu L, Lu W, Ma Z and Li Z: Oxymatrine
attenuates bleomycin-induced pulmonary fibrosis in mice via the
inhibition of inducible nitric oxide synthase expression and the
TGF-β/Smad signaling pathway. Int J Mol Med. 29:815–822.
2012.PubMed/NCBI
|
|
20
|
Zhang TZ, Fu Q, Chen T and Ma SP:
Anti-asthmatic effects of oxymatrine in a mouse model of allergic
asthma through regulating CD40 signaling. Chin J Nat Med.
13:368–374. 2015.PubMed/NCBI
|
|
21
|
Zhao P, Zhou R, Li HN, Yao WX, Qiao HQ,
Wang SJ, Niu Y, Sun T, Li YX and YU JQ: Oxymatrine attenuated
hypoxic-ischemic brain damage in neonatal rats via improving
antioxidant enzyme activities and inhibiting cell death. Neurochem
Int. 89:17–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, Bi T, Dai W, Wang G, Qian L, Gao Q
and Shen G: Effects of oxymatrine on the proliferation and
apoptosis of human hepatoma carcinoma cells. Technol Cancer Res
Treat. May 24–2015.Epub ahead of print.
|
|
23
|
Cohen SM: Cell proliferation and
carcinogenesis. Drug Metab Rev. 30:339–357. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suda T: Physiological and pathological
roles of apoptosis. Nihon Rinsho. 63(Suppl 4): 395–400. 2005.
|
|
25
|
Zörnig M, Hueber A, Baum W and Evan G:
Apoptosis regulators and their role in tumorigenesis. Biochim
Biophys Acta. 1551:F1–F37. 2001.PubMed/NCBI
|
|
26
|
Cheng YM, Chou CY, Hsu YC, Chen MJ and
Wing LY: The role of human papillomavirus type 16 E6/E7
oncoproteins in cervical epithelial-mesenchymal transition and
carcinogenesis. Oncol Lett. 3:667–671. 2012.PubMed/NCBI
|
|
27
|
Hamada K, Shirakawa T, Gotoh A, Roth JA
and Follen M: Adenovirus-mediated transfer of human papillomavirus
16 E6/E7 antisense RNA and induction of apoptosis in cervical
cancer. Gynecol Oncol. 103:820–830. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou J, Peng C, Li B, Wang F, Zhou C, Hong
D, Ye F, Cheng X, Lü W and Xie X: Transcriptional gene silencing of
HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in
vivo. Gynecol Oncol. 124:296–302. 2012. View Article : Google Scholar
|
|
29
|
Wu XN and Wang GJ: Experimental studies of
oxymatrine and its mechanisms of action in hepatitis B and C viral
infections. Chin j Dig Dis. 5:12–16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yao N and Wang X: In vitro
immunomodulatory activity of oxymatrine on Toll-like receptor 9
signal pathway in chronic hepatitis B. Am J Chin Med. 42:1399–1410.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin M, Yang LY, Li WY, Peng YP and Zheng
JK: Inhibition of the replication of hepatitis B virus in vitro by
oxymatrine. J Int Med Res. 37:1411–1419. 2009. View Article : Google Scholar : PubMed/NCBI
|
